Pfizer Inc.
Site-specific integration
Last updated:
Abstract:
The present invention relates to stable and high-producing site-specific integration (SSI) host cells, e. g. Chinese hamster ovary (CHO)-derived host cells, methods to produce and to use them.
Status:
Grant
Type:
Utility
Filling date:
31 Oct 2018
Issue date:
10 May 2022